STAA
STAAR Surgical Company
$22.36
Stable Earnings Power
40%
P/Adj-EPS × Normalized Multiple
Strong
·
Conviction
Overvalued
Trading 246.7% above fair value
You pay
$22.36
Bear
$5.16
Fair
$6.45
Bull
$7.74
Bear
$5.16
-76.9%
$0.43 × 12x P/E
Fair
$6.45
-71.2%
$0.43 × 15x P/E
Bull
$7.74
-65.4%
$0.43 × 18x P/E
Adjust Assumptions
15.0x
0.43$
Key Value Driver
Normalized P/E multiple (15x base case)
Implied Market Multiple
52.0x
Analyst Consensus (External Reference)
Never blended into the bear/base/bull estimates above.
Average Target (16 analysts)
$30.89
Divergence from AlphaVal
79%
Summary
Applying a 15x P/E to adjusted EPS of $0.43, the base-case value is $6.45 per share.
Warnings
Wall Street's average price target is $30.89 (from 16 analysts). Our estimate is 79% below the consensus -- consider that gap carefully.
Key Risks
- Growth DCF inappropriate — terminal value assumptions dominate
- EV/EBITDA misleading for regulated businesses where capex is mandated
- Regulatory risk is a fat tail not visible in normal multiples